Fifth Third Bancorp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206M Buy
418,258
+89,478
+27% +$48.6M 0.38% 54
2025
Q4
$191M Buy
328,780
+1,115
+0.3% +$631K 0.61% 37
2025
Q3
$159M Buy
327,665
+6,440
+2% +$3M 0.51% 44
2025
Q2
$130M Sell
321,225
-26,156
-8% -$10.9M 0.45% 53
2025
Q1
$173M Buy
347,381
+12,328
+4% +$6.68M 0.66% 34
2024
Q4
$174M Buy
335,053
+34,917
+12% +$19.2M 0.63% 34
2024
Q3
$186M Buy
300,136
+399
+0.1% +$236K 0.67% 35
2024
Q2
$166M Sell
299,737
-1,334
-0.4% -$764K 0.63% 34
2024
Q1
$175M Buy
301,071
+1,729
+0.6% +$970K 0.68% 33
2023
Q4
$159M Sell
299,342
-18,260
-6% -$8.84M 0.68% 36
2023
Q3
$161M Sell
317,602
-3,653
-1% -$1.95M 0.75% 32
2023
Q2
$168M Buy
321,255
+10,194
+3% +$5.5M 0.74% 29
2023
Q1
$179M Buy
311,061
+2,335
+0.8% +$1.32M 0.83% 24
2022
Q4
$170M Sell
308,726
-18,171
-6% -$9.63M 0.82% 29
2022
Q3
$166M Buy
326,897
+6,505
+2% +$3.64M 0.87% 25
2022
Q2
$174M Buy
320,392
+3,722
+1% +$2.05M 0.84% 26
2022
Q1
$187M Sell
316,670
-6,944
-2% -$3.99M 0.76% 27
2021
Q4
$216M Buy
323,614
+3,632
+1% +$2.27M 0.84% 27
2021
Q3
$183M Sell
319,982
-2,147
-0.7% -$1.18M 0.79% 28
2021
Q2
$163M Sell
322,129
-4,205
-1% -$1.98M 0.71% 30
2021
Q1
$149M Sell
326,334
-19,553
-6% -$9.33M 0.69% 31
2020
Q4
$161M Buy
345,887
+456
+0.1% +$214K 0.79% 27
2020
Q3
$153M Buy
345,431
+2,920
+0.9% +$1.21M 0.84% 23
2020
Q2
$124M Buy
342,511
+8,070
+2% +$2.7M 0.74% 28
2020
Q1
$94.8M Buy
334,441
+6,006
+2% +$1.89M 0.68% 33
2019
Q4
$107M Buy
328,435
+23,270
+8% +$7.06M 0.59% 43
2019
Q3
$88.9M Buy
305,165
+39,820
+15% +$11.4M 0.53% 49
2019
Q2
$77.9M Buy
265,345
+54,800
+26% +$15.1M 0.48% 55
2019
Q1
$57.6M Buy
210,545
+24,035
+13% +$5.98M 0.37% 75
2018
Q4
$41.7M Buy
186,510
+29,019
+18% +$6.81M 0.3% 93
2018
Q3
$38.4M Buy
157,491
+20,730
+15% +$4.77M 0.24% 107
2018
Q2
$28.3M Buy
136,761
+30,030
+28% +$6.37M 0.19% 130
2018
Q1
$22M Buy
106,731
+16,259
+18% +$3.41M 0.15% 140
2017
Q4
$17.2M Buy
90,472
+26,811
+42% +$5.14M 0.12% 160
2017
Q3
$12M Buy
63,661
+9,892
+18% +$1.79M 0.09% 188
2017
Q2
$9.38M Buy
53,769
+9,373
+21% +$1.57M 0.07% 213
2017
Q1
$6.82M Sell
44,396
-2,023
-4% -$309K 0.05% 254
2016
Q4
$6.55M Sell
46,419
-750
-2% -$111K 0.05% 252
2016
Q3
$7.5M Sell
47,169
-731
-2% -$113K 0.06% 227
2016
Q2
$7.08M Sell
47,900
-2,247
-4% -$332K 0.06% 230
2016
Q1
$7.1M Buy
50,147
+1,352
+3% +$181K 0.06% 240
2015
Q4
$6.92M Sell
48,795
-5,105
-9% -$681K 0.06% 228
2015
Q3
$6.59M Buy
53,900
+184
+0.3% +$24K 0.06% 233
2015
Q2
$6.97M Sell
53,716
-6,442
-11% -$840K 0.06% 233
2015
Q1
$8.08M Sell
60,158
-945
-2% -$122K 0.07% 225
2014
Q4
$7.66M Sell
61,103
-6,781
-10% -$825K 0.07% 239
2014
Q3
$8.26M Buy
67,884
+785
+1% +$95.4K 0.08% 221
2014
Q2
$7.92M Sell
67,099
-7,558
-10% -$890K 0.07% 228
2014
Q1
$8.98M Sell
74,657
-347
-0.5% -$41.3K 0.08% 200
2013
Q4
$8.35M Sell
75,004
-63,128
-46% -$6.28M 0.08% 202
2013
Q3
$12.7M Sell
138,132
-13,131
-9% -$1.19M 0.13% 149
2013
Q2
$12.8M Buy
+151,263
New +$12.6M 0.14% 145

Other funds holding TMO

Fifth Third Bancorp's TMO Position: Q1 2026 in Review

Fifth Third Bancorp increased its Thermo Fisher Scientific (TMO) stake by 27% in Q1 2026, buying an estimated $48.6M and bringing the position to 418,258 shares worth $206M. The position accounts for 0.38% of the portfolio, ranked #54.

Fifth Third Bancorp first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $216M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Fifth Third Bancorp held 418,258 shares of Thermo Fisher Scientific worth $206M as of Q1 2026.
  • Fifth Third Bancorp bought 89,478 Thermo Fisher Scientific shares in Q1 2026, an estimated $48.6M.
  • Thermo Fisher Scientific made up 0.38% of Fifth Third Bancorp's portfolio in Q1 2026, its #54 holding.
  • Fifth Third Bancorp first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's Thermo Fisher Scientific position peaked at $216M in Q4 2021.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.